Literature DB >> 26856915

Modeling Key Malaria Drugs' Impact on Global Health: A Reason to Invest in the Global Health Impact Index.

Nicole Hassoun1.   

Abstract

Millions of people cannot access good quality essential medicines they need for some of the world's worst diseases like malaria. The World Health Organization estimates that, in 2013, 198 million people became sick with malaria and 584,000 people died of the disease, while the Institute for Health Metrics Evaluation estimates that there were 164,929,872 cases of malaria in 2013 and 854,568 deaths in 2013. There are many attempts to model different aspects of the global burden of tropical diseases like malaria, but it is also important to measure success in averting malaria-related death and disability. This perspective proposes investing in a systematic effort to measure the benefits of health interventions for malaria along the lines of a model embodied in the Global Health Impact Index (global-health-impact.org). © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26856915      PMCID: PMC4856624          DOI: 10.4269/ajtmh.15-0409

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  20 in total

1.  Global health impact: a basis for labeling and licensing campaigns?

Authors:  Nicole Hassoun
Journal:  Dev World Bioeth       Date:  2012-02-07       Impact factor: 2.294

2.  Policy brief on improving access to artemisinin-based combination therapies for malaria control in Ethiopia.

Authors:  Amha Kebede; Adugna Woyessa; Kelbessa Urga; Tsehaynesh Messelle; Daddi Jima
Journal:  Int J Technol Assess Health Care       Date:  2010-04       Impact factor: 2.188

3.  The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya.

Authors:  Raymond K Sudoi; Sophie Githinji; Andrew Nyandigisi; Alex Muturi; Robert W Snow; Dejan Zurovac
Journal:  Malar J       Date:  2012-02-08       Impact factor: 2.979

4.  Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007.

Authors:  Ryuichi Komatsu; Eline L Korenromp; Daniel Low-Beer; Catherine Watt; Christopher Dye; Richard W Steketee; Bernard L Nahlen; Rob Lyerla; Jesus M Garcia-Calleja; John Cutler; Bernhard Schwartländer
Journal:  BMC Infect Dis       Date:  2010-04-30       Impact factor: 3.090

5.  Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum.

Authors:  J Teun Bousema; Petra Schneider; Louis C Gouagna; Chris J Drakeley; Alma Tostmann; Rein Houben; John I Githure; Rosalynn Ord; Colin J Sutherland; Sabah A Omar; Robert W Sauerwein
Journal:  J Infect Dis       Date:  2006-03-15       Impact factor: 5.226

Review 6.  A research agenda for malaria eradication: health systems and operational research.

Authors: 
Journal:  PLoS Med       Date:  2011-01-25       Impact factor: 11.069

7.  Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data.

Authors:  Anne E P Frosch; Meera Venkatesan; Miriam K Laufer
Journal:  Malar J       Date:  2011-05-09       Impact factor: 2.979

8.  Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.

Authors:  Paul N Newton; Michael D Green; Dallas C Mildenhall; Aline Plançon; Henry Nettey; Leonard Nyadong; Dana M Hostetler; Isabel Swamidoss; Glenn A Harris; Kristen Powell; Ans E Timmermans; Abdinasir A Amin; Stephen K Opuni; Serge Barbereau; Claude Faurant; Ray C W Soong; Kevin Faure; Jonarthan Thevanayagam; Peter Fernandes; Harparkash Kaur; Brian Angus; Kasia Stepniewska; Philippe J Guerin; Facundo M Fernández
Journal:  Malar J       Date:  2011-12-13       Impact factor: 2.979

9.  The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015.

Authors:  S Bhatt; D J Weiss; E Cameron; D Bisanzio; B Mappin; U Dalrymple; K Battle; C L Moyes; A Henry; P A Eckhoff; E A Wenger; O Briët; M A Penny; T A Smith; A Bennett; J Yukich; T P Eisele; J T Griffin; C A Fergus; M Lynch; F Lindgren; J M Cohen; C L J Murray; D L Smith; S I Hay; R E Cibulskis; P W Gething
Journal:  Nature       Date:  2015-09-16       Impact factor: 49.962

10.  A new infectious disease model for estimating and projecting HIV/AIDS epidemics.

Authors:  Le Bao
Journal:  Sex Transm Infect       Date:  2012-10-30       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.